Adage Capital Partners Gp, L.L.C. Ultragenyx Pharmaceutical Inc. Put Options Transaction History
Adage Capital Partners Gp, L.L.C.
- $56.4 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RARE
# of Institutions
364Shares Held
88.1MCall Options Held
3.64MPut Options Held
2.24M-
Vanguard Group Inc Valley Forge, PA10.2MShares$304 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$167 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.94MShares$117 Million0.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.89MShares$85.8 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY2.77MShares$82.5 Million1.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.08B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...